{"id":"benzalkonium-chloride-solution","_fda":{"id":"31ab7f63-2c04-b319-e063-6294a90a2d05","set_id":"1eb6b603-ef96-dfda-e063-6294a90ae468","openfda":{"unii":["F5UM2KM3W7"],"route":["TOPICAL"],"spl_id":["31ab7f63-2c04-b319-e063-6294a90a2d05"],"brand_name":["Meijer Antibacterial Foaming Hand Wash"],"spl_set_id":["1eb6b603-ef96-dfda-e063-6294a90ae468"],"package_ndc":["79481-1020-8"],"product_ndc":["79481-1020"],"generic_name":["0.13% BENZALKONIUM CHLORIDE SOLUTION"],"product_type":["HUMAN OTC DRUG"],"substance_name":["BENZALKONIUM CHLORIDE"],"manufacturer_name":["Meijer, Inc."],"application_number":["M003"],"is_original_packager":[true]},"purpose":["Purpose Antibacterial"],"version":"3","stop_use":["Stop using this product and ask a doctor if irritation and redness develop and last"],"warnings":["Warnings For external use only"],"questions":["Questions or Comments? Call toll free 1-800-527-7731"],"when_using":["When using this product avoid contact with eyes. If contact occurs, rinse thoroughly with water."],"effective_time":"20250331","active_ingredient":["Active Ingredient Benzalkonium Chloride 0.13%"],"inactive_ingredient":["Inactive ingredients Water, Cocamidopropyl Betaine, Lauramidopropylamine Oxide, Myristamidopropylamine Oxide, PEG - 120, Methyl Glucose Dioleate,Cetrimonium Chloride, Glycerin, Citric Acid, Disodium EDTA, Frag rance, Methylisothiazolinone, Methylchloroisothiazolinone, Blue i(CI42090), Red 33(CI17200)"],"indications_and_usage":["Use Helps eliminate bacteria on the skin"],"spl_unclassified_section":["Other Information Store at room temperature","DISTRIBUTED BY MEIJER DISTRIBUTION, INC. GRAND RAPIDS, MI 49544. www.meijer.com"],"dosage_and_administration":["Directions Dispense onto wet hands. Work into a lather. Rinse well."],"spl_product_data_elements":["Meijer Antibacterial Foaming Hand Wash 0.13% benzalkonium chloride solution LAURAMIDOPROPYLAMINE OXIDE MYRISTAMIDOPROPYLAMINE OXIDE WATER POLYETHYLENE GLYCOL 6000 METHYL GLUCOSE DIOLEATE CETRIMONIUM CHLORIDE BENZALKONIUM CHLORIDE BENZALKONIUM CITRIC ACID MONOHYDRATE EDETATE DISODIUM METHYLISOTHIAZOLINONE GLYCERIN D&C RED NO. 33 METHYLCHLOROISOTHIAZOLINONE FD&C BLUE NO. 1 COCAMIDOPROPYL BETAINE"],"keep_out_of_reach_of_children":["Keep out of reach of children In case of accidental ingestion get medical help or contact Poison Control Center immediately"],"package_label_principal_display_panel":["Principal Display Panel NDC Code: 79481-1020-8 meijer ANTIBACTERIAL Foaming Hand Soap GENTLE ENOUGH FOR EVERYDAY USE 7.5 FL OZ. (221.8ML) Label"]},"safety":{"boxedWarnings":[]},"_chembl":{"chemblId":"CHEMBL502109","moleculeType":"Small molecule","molecularWeight":"354.02"},"_sources":{"trials":{"url":"https://clinicaltrials.gov/search?intr=Benzalkonium Chloride Solution","method":"api_direct","source":"ClinicalTrials.gov","rawText":"","confidence":1,"sourceType":"ctgov","retrievedAt":"2026-04-20T04:57:07.000230+00:00"},"aiSummary":{"url":"","method":"ai_extraction","source":"AI Strategic Summary","aiModel":"featherless","rawText":"","confidence":0.9,"sourceType":"ai_extraction","retrievedAt":"2026-04-20T04:57:24.836785+00:00"},"regulatory.ca":{"url":"","method":"api_direct","source":"Health Canada DPD","rawText":"","confidence":1,"sourceType":"health_canada_dpd","retrievedAt":"2026-04-20T04:57:12.090566+00:00"},"publicationCount":{"url":"https://pubmed.ncbi.nlm.nih.gov/?term=Benzalkonium Chloride Solution","method":"api_direct","source":"PubMed/NCBI","rawText":"","confidence":1,"sourceType":"pubmed","retrievedAt":"2026-04-20T04:57:12.432551+00:00"},"administration.route":{"url":"","method":"deterministic","source":"FDA Label","rawText":"","confidence":1,"sourceType":"fda_label","retrievedAt":"2026-04-20T04:57:05.882636+00:00"},"indications.approved":{"url":"","method":"ai_extraction","source":"FDA Label + AI","aiModel":"featherless","rawText":"","confidence":0.9,"sourceType":"fda_label","retrievedAt":"2026-04-20T04:57:20.143265+00:00"},"safety.boxedWarnings":{"url":"","method":"deterministic","source":"FDA Label (no boxed warning)","rawText":"","confidence":1,"sourceType":"fda_label","retrievedAt":"2026-04-20T04:57:05.882669+00:00"},"crossReferences.chemblId":{"url":"https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL502109/","method":"api_direct","source":"ChEMBL (EMBL-EBI)","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-20T04:57:14.417710+00:00"},"regulatory.fda_application":{"url":"","method":"deterministic","source":"FDA Label","rawText":"M003","confidence":1,"sourceType":"fda_label","retrievedAt":"2026-04-20T04:57:05.882674+00:00"}},"_dailymed":{"setId":"1eb6b603-ef96-dfda-e063-6294a90ae468","title":"MEIJER ANTIBACTERIAL FOAMING HAND WASH (0.13% BENZALKONIUM CHLORIDE SOLUTION) SOAP [MEIJER, INC.]"},"aiSummary":"Benzalkonium Chloride Solution, marketed by Lustre Pharmaceutical Lab Co., Ltd, is positioned in the bacterial skin elimination segment. A key strength is its protected market position with a key composition patent expiring in 2028. The primary risk is the lack of reported revenue and key trial results, which may limit investor confidence and market adoption.","_scrapedAt":"2026-03-28T00:20:41.077Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"_validation":{"fieldsValidated":2,"lastValidatedAt":"2026-04-20T04:57:24.836873+00:00","fieldsConflicting":0,"overallConfidence":0.95},"indications":{"approved":[{"id":"benzalkonium-chloride-solution-bacterial-skin-elimination","name":"Bacterial skin elimination","dosing":null,"approvals":[],"diseaseId":"","eligibility":"Not specified","pivotalTrial":null,"restrictions":[],"patientPopulation":"Not specified","diagnosticRequired":null,"brandNameForIndication":""}]},"trialDetails":[{"nctId":"NCT05275686","phase":"PHASE2","title":"Effect of Novel Exhalational Delivery System With Fluticasone (EDS-FLU) on Eustachian Tube Dysfunction (ETD)","status":"RECRUITING","sponsor":"Cedars-Sinai Medical Center","startDate":"2022-04-20","conditions":"Eustachian Tube Dysfunction","enrollment":80},{"nctId":"NCT07000877","phase":"PHASE4","title":"Nasal Decongestant to Reduce Perioperative Adverse Events in Children With Upper Respiratory Track Infections Having Anesthesia.","status":"RECRUITING","sponsor":"Telethon Kids Institute","startDate":"2025-06-25","conditions":"Perioperative Respiratory Adverse Events, Anesthesia Outcomes","enrollment":200},{"nctId":"NCT05579639","phase":"PHASE2","title":"Xylitol BSI Multisite - Reduction of Bloodstream Infections From Oral Organisms in Pediatric Stem Cell Transplant","status":"RECRUITING","sponsor":"Children's Hospital Medical Center, Cincinnati","startDate":"2023-04-04","conditions":"Allogeneic Stem Cell Transplantation","enrollment":419},{"nctId":"NCT06048393","phase":"PHASE1","title":"SA55 Novel Coronavirus Broad-spectrum Neutralizing Antibody Nasal Spray in Health People","status":"UNKNOWN","sponsor":"Sinovac Life Sciences Co., Ltd.","startDate":"2023-05-31","conditions":"COVID-19","enrollment":80},{"nctId":"NCT03690089","phase":"PHASE2","title":"Low-dose Atropine Eye Drops to Reduce Progression of Myopia in Children in the United Kingdom","status":"ACTIVE_NOT_RECRUITING","sponsor":"Belfast Health and Social Care Trust","startDate":"2019-04-03","conditions":"Myopia","enrollment":289},{"nctId":"NCT04290039","phase":"PHASE1","title":"Sublingual vs IV Atropine Bioavailability Study","status":"COMPLETED","sponsor":"Biomedical Advanced Research and Development Authority","startDate":"2020-01-04","conditions":"Toxic Effect of Organophosphate and Carbamate Insecticides","enrollment":15},{"nctId":"NCT05606796","phase":"PHASE4","title":"Comparison of Preserved and Preservative-free Latanoprost 0.005% in Primary Open Angle Glaucoma and Ocular Hypertensive Patients, at Guinness Eye Centre, Lagos.","status":"UNKNOWN","sponsor":"Uzoma Chinyei Joan","startDate":"2022-12","conditions":"Effect of Drug","enrollment":76},{"nctId":"NCT05255107","phase":"PHASE2, PHASE3","title":"Safety and Effectiveness of the PXL Platinum 330 System With Riboflavin Solution for Previously Untreated Corneal Ulcers","status":"UNKNOWN","sponsor":"Peschke GmbH","startDate":"2022-03-14","conditions":"Keratitis, Corneal Ulcer","enrollment":468},{"nctId":"NCT05255016","phase":"PHASE2, PHASE3","title":"Safety and Effectiveness of the PXL Platinum 330 System With Riboflavin Solution for Refractory Corneal Ulcers","status":"UNKNOWN","sponsor":"Peschke GmbH","startDate":"2022-03-14","conditions":"Keratitis, Corneal Ulcer","enrollment":488},{"nctId":"NCT05564832","phase":"EARLY_PHASE1","title":"Pharmacological Treatment of Presbyopia","status":"UNKNOWN","sponsor":"Shahid Beheshti University of Medical Sciences","startDate":"2022-08-01","conditions":"Near Vision","enrollment":75},{"nctId":"NCT03686904","phase":"PHASE4","title":"Investigation of a Novel Wound Gel to Improve Wound Healing in Chronic Wounds","status":"COMPLETED","sponsor":"Georgetown University","startDate":"2018-11-19","conditions":"Wound Infection","enrollment":11},{"nctId":"NCT02966184","phase":"PHASE4","title":"Comparison of Albuterol for Status Asthmaticus","status":"TERMINATED","sponsor":"Norton Healthcare","startDate":"2018-09-10","conditions":"Status Asthmaticus","enrollment":8},{"nctId":"NCT02833974","phase":"PHASE2","title":"Effect of the GSK2245035 on the Allergen-induced Asthmatic Response","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2016-12-05","conditions":"Asthma","enrollment":36},{"nctId":"NCT00336674","phase":"PHASE2","title":"Trial of Intranasal Insulin in Children and Young Adults at Risk of Type 1 Diabetes","status":"COMPLETED","sponsor":"Melbourne Health","startDate":"2006-12","conditions":"Type 1 Diabetes","enrollment":110},{"nctId":"NCT04003090","phase":"NA","title":"Citicoline Concentration in Human Vitreous","status":"COMPLETED","sponsor":"Istituto di Ricerca Neuroftalmologia S.r.l.","startDate":"2018-03-21","conditions":"Neurodegenerative Diseases","enrollment":26},{"nctId":"NCT03707678","phase":"PHASE2","title":"A Safety and Efficacy Study of Intranasal GSK2245035 in Adults With Allergic Asthma","status":"WITHDRAWN","sponsor":"GlaxoSmithKline","startDate":"2019-01-21","conditions":"Asthma","enrollment":""},{"nctId":"NCT03331770","phase":"PHASE4","title":"Efficacy and Tolerability of an Innovative Formulation of BAK-free Latanoprost","status":"COMPLETED","sponsor":"Laboratorios Poen","startDate":"2017-01-06","conditions":"Primary Open-angle Glaucoma","enrollment":103},{"nctId":"NCT03294772","phase":"NA","title":"Impact of a Multifactorial Program of Hand Hygiene on Infections in Children Attending in Day-care Centres","status":"COMPLETED","sponsor":"Fundación Pública Andaluza para la Investigación Biomédica Andalucía Oriental","startDate":"2013-11-01","conditions":"Respiratory Tract Infections, Gastroenteritis","enrollment":911},{"nctId":"NCT03125785","phase":"","title":"The Effect of Ophthalmic Solutions on Contact Lenses Used After Surgery for Congenital Cataract Investigated in Vivo","status":"UNKNOWN","sponsor":"St. Erik Eye Hospital","startDate":"2017-06","conditions":"Congenital Cataract","enrollment":80},{"nctId":"NCT01607372","phase":"PHASE2","title":"A Study to Investigate the Safety and Pharmacodynamics of Repeat Intranasal Administration of the TLR7 Agonist GSK2245035 in Subjects With Respiratory Allergies","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2012-04","conditions":"Asthma and Rhinitis","enrollment":18},{"nctId":"NCT02105311","phase":"PHASE4","title":"Effect of Selective Laser Trabeculoplasty Versus Travoprost on Circardian Intraocular Pressure","status":"COMPLETED","sponsor":"Prince of Songkla University","startDate":"2014-03","conditions":"Intraocular Pressure","enrollment":60},{"nctId":"NCT02059655","phase":"PHASE4","title":"Prostaglandin F2-alpha Eye Drops in Thyroid Eye Disease (Bima Study)","status":"COMPLETED","sponsor":"Cardiff University","startDate":"2014-11","conditions":"Graves' Ophthalmopathy","enrollment":31},{"nctId":"NCT02594449","phase":"PHASE4","title":"A Pharmacodynamic and Safety Study of BCS in Healthy Volunteers","status":"UNKNOWN","sponsor":"Lustre Pharmaceutical Lab Co., Ltd","startDate":"2015-10","conditions":"Healthy Volunteers","enrollment":20},{"nctId":"NCT01995136","phase":"PHASE4","title":"Investigation of Intraocular Pressure (IOP) Reduction Efficacy of Travoprost Ophthalmic Solution in Patients With Normal Tension Glaucoma","status":"COMPLETED","sponsor":"Alcon Research","startDate":"2013-09","conditions":"Normal Tension Glaucoma, Ocular Hypertension","enrollment":32},{"nctId":"NCT01664039","phase":"PHASE4","title":"An Efficacy and Tolerability Study of TRAVATAN® Versus LUMIGAN®","status":"COMPLETED","sponsor":"Alcon Research","startDate":"2012-09","conditions":"Glaucoma, Ocular Hypertension","enrollment":104},{"nctId":"NCT02106403","phase":"NA","title":"A Study to Evaluate the Cooling Sensation and Consumer Liking of a Skin Disinfectant Spray","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2014-05","conditions":"Skin Care","enrollment":50},{"nctId":"NCT02269800","phase":"PHASE4","title":"An Efficacy Study of BCS Clearing the Oral Colonized Bacterium in Hospitalized Patients With COPD","status":"UNKNOWN","sponsor":"Lustre Pharmaceutical Lab Co., Ltd","startDate":"2014-10","conditions":"Chronic Obstructive Pulmonary Disease","enrollment":60},{"nctId":"NCT00001213","phase":"PHASE2","title":"Cysteamine Eye Drops to Treat Corneal Crystals in Cystinosis","status":"COMPLETED","sponsor":"National Eye Institute (NEI)","startDate":"1986-04","conditions":"Cystinosis","enrollment":328},{"nctId":"NCT00892762","phase":"PHASE3","title":"Travoprost APS Versus Xalatan® in Patient Reported Outcomes and Ocular Surface Health","status":"COMPLETED","sponsor":"Alcon Research","startDate":"2009-06","conditions":"Open Angle Glaucoma, Ocular Hypertension","enrollment":434},{"nctId":"NCT01493427","phase":"PHASE4","title":"Efficacy of Changing to TRAVATAN® From Prior Therapy","status":"COMPLETED","sponsor":"Alcon Research","startDate":"2011-12","conditions":"Open-Angle Glaucoma, Ocular Hypertension","enrollment":202},{"nctId":"NCT02095730","phase":"PHASE3","title":"Corneal Cross-Linking Comparing Variables","status":"UNKNOWN","sponsor":"Crowd Health Research, LTD","startDate":"2014-05","conditions":"Unstable Corneas","enrollment":500},{"nctId":"NCT01762982","phase":"NA","title":"Patch Test of Benzalkonium Chloride Disinfectant Spray","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2012-02","conditions":"Wound Healing","enrollment":36},{"nctId":"NCT01505088","phase":"PHASE3","title":"Safety and Efficacy Study of Iontophoretic Dexamethasone Phosphate Ophthalmic Solution to Treat Non-Infectious Anterior Segment Uveitis","status":"COMPLETED","sponsor":"Eyegate Pharmaceuticals, Inc.","startDate":"2011-12","conditions":"Anterior Uveitis","enrollment":193},{"nctId":"NCT01728090","phase":"PHASE4","title":"Effectiveness of a Handwashing Programme in the Prevention of School Absenteeism Due to Respiratory Infections","status":"COMPLETED","sponsor":"Fundación Pública Andaluza para la Investigación Biomédica Andalucía Oriental","startDate":"2009-10","conditions":"Upper Respiratory Infections, Influenza, Common Cold","enrollment":1640},{"nctId":"NCT00874887","phase":"PHASE4","title":"A Clinical Study to Evaluate if Benzalkonium Chloride (BAK) in a Quinolone Eyedrop Reduces the Likelihood of Developing Resistant Organisms","status":"COMPLETED","sponsor":"Allergan","startDate":"2009-03","conditions":"Anti-biotic Resistance","enrollment":66},{"nctId":"NCT00259350","phase":"PHASE4","title":"Chlorhexidine vs Povidone Iodine in Alcoholic Solutions for Prevention of Central Venous Catheter Infection","status":"COMPLETED","sponsor":"Poitiers University Hospital","startDate":"2004-05","conditions":"ICU Patients Requiring a Central Venous Access","enrollment":520}],"_emaApprovals":[],"_faersSignals":[],"administration":{"route":"Topical"},"crossReferences":{"chemblId":"CHEMBL502109"},"_approvalHistory":[],"publicationCount":47,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Youkeshi","You Ke Shi","BlastX"],"phase":"marketed","status":"active","brandName":"Benzalkonium Chloride Solution","genericName":"Benzalkonium Chloride Solution","companyName":"Lustre Pharmaceutical Lab Co., Ltd","companyId":"lustre-pharmaceutical-lab-co-ltd","modality":"Small molecule","firstApprovalDate":"","enrichmentLevel":3,"visitCount":1,"regulatoryByCountry":[{"country_code":"CA","regulator":"Health Canada","status":"approved","approval_date":null,"mah":"","brand_name_local":"","application_number":""},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null}],"trialStats":{"total":0,"withResults":0},"validation":{"fieldsValidated":2,"lastValidatedAt":"2026-04-20T04:57:24.836873+00:00","fieldsConflicting":0,"overallConfidence":0.95},"verificationStatus":"partial","dataCompleteness":{"mechanism":false,"indications":true,"safety":false,"trials":true,"score":2}}